A recent high-profile paper suggesting that science is becoming dramatically less disruptive set the academic world abuzz. One interpretation of this finding — though by no means the only one — is ...
Combination therapy with avelumab (Ave) and cabozantinib (Cabo) in patients (pts) with newly diagnosed metastatic clear cell renal cell carcinoma (mccRCC). This is an ASCO Meeting Abstract from the ...
Following our recent announcement about the Evidence Synthesis Skills Framework, we are pleased to introduce a new, free course developed alongside the framework by evidence synthesis experts of the ...
The Texas A&M Agriculture, Food and Nutrition Evidence Center has named Maureen Spill, Ph.D., as its first associate director. Maureen Spill, Ph.D., has been appointed as the associate director at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results